Alexza Pharma (NASDAQ: ALXA) engages in the research, development, and commercialization of novel proprietary products for the acute treatment of central nervous system conditions. Its product candidates are based on a proprietary technology, the Staccato system, which vaporizes an excipient-free…
BillMyParents, Inc. (BMPI.OB) Due Diligence.
BillMyParents, Inc. (BMPI.OB) Due Diligence. UPDATED 11/27/12: BillMyParents has entered into a spokesman agreement with Justin Bieber, so the rumors I heard from months ago finally turn out to be correct. I expect more news on this tomorrow to supplement…
Near Term Catalysts For Anacor Pharma Should Make For Nice Upside Gain
Trading biophama companies before a catalyst event, if done correctly, can be a very profitable proposition. Some traders and investors who enjoy bringing more risk into play often times will hold through the actual catalyst event. While this does bring…
Video Blog: Hurricane Sandy Aftermath + Promised Commentary on $ATRS
Video Blog: Hurricane Sandy Aftermath + Promised Commentary on $ATRS: During this holiday season, please remember those who are far less fortunate than us. These people really need our help — anything helps, so please donate what you can. Also,…
BioPharma Video Update With Charts and Commentary — Happy Thanksgiving!
Happy Thanksgiving to everyone out there! Please remember — be thankful for family and if you have family members you have issues with, forgive and be forgiven! In this video update, I cover $AVEO, $BGMD, and $ARNA. Also, I offer…
Upcoming Catalyst Event For Aveo Pharma May Provoke A Short Squeeze
AVEO Pharmaceuticals (AVEO) is dedicated to discovering, developing and commercializing targeted therapies to impact the lives of patients living with cancer. The company has built a pipeline of anti-cancer therapeutics through the use of its proprietary Human Response Platform™. The…
Small Cap Bio-Pharmas For Possible Long Side Trades
With some added confidence shown by investors yesterday, it’s a good time to look at some “risk on” small cap bio-pharma stocks that I feel offer good upside for both swing trades and longer term holds. However, with the looming…
Explanation On Why Market Could Tank By July 2013
Before and since President Obama won reelection a little over a week ago, the market has been sharply down just about every day. Is this cause for concern? Yes it is, and I will explain why in this write-up. The…
Upcoming BioPharma Catalyst Trades to Consider
Trading BioPhama stocks before a catalyst event, if done correctly can be a very profitable proposition, but if traded in a wrong manner, can cause losses. I remarked in an article from March of this year that Horizon Pharma (NASDAQ:…
November 10 Biotech Update
This past week was a bit rough on the overall markets as on Tuesday, the markets seemed to bet on a Romney win, only to sell off the next day on news of an Obama win. The good news for…
